Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Option Care Health to Participate in the TD Cowen Healthcare Conference

2026-01-29
BANNOCKBURN, Ill., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 46th Annual TD Cowen Healthcare Conference, being held in Boston, MA, on Tuesday, March 3, 2026, including a fireside chat at 1:10pm ET. The webcast will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nat

Why Option Care (OPCH) Could Beat Earnings Estimates Again

2026-01-27
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call

2026-01-21
BANNOCKBURN, Ill., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year 2025 on Tuesday, February 24, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsP

1 Healthcare Stock Worth Your Attention and 2 We Avoid

2026-01-16
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.

Assessing Option Care Health (OPCH) Valuation After New 2025 Outlook And US$1b Buyback Expansion

2026-01-16
Option Care Health (OPCH) is back in focus after releasing preliminary 2025 revenue and earnings figures, along with fresh 2026 guidance and a much larger share buyback program that helped drive the latest stock reaction. See our latest analysis for Option Care Health. The preliminary 2025 figures and expanded US$1.0b buyback have come on the back of strong recent momentum, with a 90 day share price return of 30.03% and a 1 year total shareholder return of 23.16%. The 5 year total shareholder...

Option Care Health (OPCH) Is Up 9.8% After Doubling Its Share Buyback Authorization to $1 Billion

2026-01-15
In recent days, Option Care Health, Inc. announced preliminary unaudited fourth-quarter and full-year 2025 results, issued 2026 guidance calling for US$5.8 billion to US$6.0 billion in net revenue, and disclosed that it has repurchased 10,038,366 shares for US$307.47 million under its existing program. The Board’s decision on January 9, 2026 to double the share repurchase authorization to US$1.0 billion, alongside ongoing buybacks equal to more than 6% of shares outstanding in 2025,...

Option Care Health: Portfolio Transformation Will Be Painful But The Growth Story Is Not Over Yet

2026-01-15
Option Care Health's Q4 2025 results show Stelara exclusivity loss, compressing margins faster than volume can offset. Check out why OPCH stock is a hold.

Option Care Health Stock Earns Healthy RS Rating Upgrade

2026-01-14
A Relative Strength Rating upgrade for Option Care Health shows improving technical performance. Will it continue?

Option Care (OPCH) Runs to Near Record on Preliminary FY25 Results

2026-01-14
We recently published 10 Stocks Leaving Wall Street in the Dust; 4 Hit Fresh Records. Option Care Health Inc. (NASDAQ:OPCH) was one of the top performers on Tuesday. Option Care extended gains for a second day on Tuesday, nearly hitting its 52-week high, as investors cheered higher preliminary net revenues for full-year 2025. At intra-day […]

Why Option Care Health Stock Zoomed 8% Higher on Tuesday

2026-01-14
As part of a preliminary earnings release, the niche healthcare company announced a doubling of its share repurchase program.